Information Provided By: 
Fly News Breaks for February 13, 2018
SRCL
Feb 13, 2018 | 09:11 EDT
As previously reported, Baird analyst David Manthey upgraded Stericycle to Neutral from Underperform. The analyst said he continues to have a negative bias on the company's fundamentals, but he sees a more balanced risk/reward following the stock's relative underperformance to the market. Manthey raised his price target to $73 from $62 on Stericycle shares.
News For SRCL From the Last 2 Days
SRCL
Apr 25, 2024 | 07:04 EDT
Completed previously disclosed workforce reduction in the first quarter of 2024 and are on track to realize an estimated $40-$45 million of in-year cost savings.
